Detalhe da pesquisa
1.
Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension-Real World Data of the Polish Lymphoma Research Group.
Heart Lung Circ
; 33(5): 675-683, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616466
2.
Primary cutaneous indolent B-cell lymphomas - a retrospective multicenter analysis and a review of literature.
Acta Oncol
; 60(10): 1361-1368, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34346830
3.
Hypomethylation of the promoter region drives ectopic expression of TMEM244 in Sézary cells.
J Cell Mol Med
; 24(18): 10970-10977, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32794659
4.
G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield.
J Clin Apher
; 32(6): 384-391, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28101890
5.
Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.
Br J Haematol
; 175(5): 884-891, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27682187
6.
The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma.
Eur J Haematol
; 94(2): 109-14, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25039659
7.
Acute Myeloid Leukemia Post Cytotoxic Therapy in Breast Cancer Survivors-Over 23 Years of Single Center Analysis.
J Clin Med
; 13(4)2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38398301
8.
Clinical outcomes of therapy-related acute myeloid leukemia: an over 20-year single-center retrospective analysis.
Pol Arch Intern Med
; 133(1)2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36165652
9.
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group.
Adv Clin Exp Med
; 32(1): 131-136, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603138
10.
The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program.
Clin Lymphoma Myeloma Leuk
; 22(6): 405-415, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933827
11.
[Thrombotic complications of central venous catheters in hematooncological patients]. / Powiklania zakrzepowe zwiazane z obecnoscia centralnych cewników zylnych u pacjentów hematoonkologicznych.
Przegl Lek
; 67(3): 217-21, 2010.
Artigo
em Polonês
| MEDLINE | ID: mdl-20687388
12.
Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP - the PLRG report.
Sci Rep
; 10(1): 3517, 2020 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32103128
13.
Evaluation of the prevalence of hepatitis C virus infection in patients with hemophilia treated in a single hemophilia center in Poland.
Pol Arch Intern Med
; 133(5)2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800802
14.
Breast implant-associated anaplastic large cell lymphoma as a late complication of breast implant placement: a report of 3 Polish cases.
Pol Arch Intern Med
; 133(7-8)2023 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37417203
15.
TMEM244 Gene Expression as a Potential Blood Diagnostic Marker Distinguishing Sézary Syndrome from Mycosis Fungoides and Benign Erythroderma.
J Invest Dermatol
; 143(2): 344-347.e3, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087622
16.
Comparative proteomic profiling of sera from patients with refractory multiple myeloma reveals potential biomarkers predicting response to bortezomib-based therapy.
Pol Arch Intern Med
; 127(6): 392-400, 2017 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28546528
17.
Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders.
Int J Cardiol
; 235: 147-153, 2017 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28268088
18.
Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes.
Onco Targets Ther
; 9: 2069-80, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27103833
19.
Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy.
Oncotarget
; 7(35): 56726-56736, 2016 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27527861
20.
Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group.
Pol Arch Med Wewn
; 125(10): 741-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26334344